Analyst Ratings for Amgen (AMGN) [Neutrals]
AMGN Rating Summary
AMGN Price Target Summary
- Highest: $130.00 (Goldman Sachs)
- Lowest: $58.00 (BMO Capital)
- Average: $88.27
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$88.27 (-11%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2013 | Piper Jaffray | Downgrade | Neutral (Overweight) |
N/A (N/A) |
112.76 | 99.18 | -12.04% | Details |
| 2/11/2013 | William Blair | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
86.77 | 99.18 | 14.3% | Details |
| 1/22/2013 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
82.08 | 99.18 | 20.83% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Neutral (N/A) |
93.00 (N/A) |
84.74 | 99.18 | 17.04% | Details |
| 9/12/2012 | Baird | Downgrade | Neutral (Outperform) |
84.00 (83.00) |
83.94 | 99.18 | 18.16% | Details |
| 3/15/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
68.26 | 99.18 | 45.3% | Details |
| 3/6/2012 | Bernstein | Downgrade | Market Perform (N/A) |
76.00 (N/A) |
67.23 | 99.18 | 47.52% | Details |
| 2/10/2012 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
66.84 | 99.18 | 48.38% | Details |
| 2/9/2012 | Oppenheimer » Updated 11/26/2012 |
Downgrade | Perform (N/A) |
89.00 (N/A) |
68.06 | 99.18 | 45.72% | Details |
| 1/23/2012 | JPMorgan | Downgrade | Neutral (N/A) |
75.00 (N/A) |
69.57 | 99.18 | 42.56% | Details |
| 12/9/2011 | Barclays | New Coverage | Equalweight (N/A) |
65.00 (N/A) |
58.41 | 99.18 | 69.8% | Details |
| 11/22/2011 | BMO Capital | Downgrade | Market Perform (N/A) |
58.00 (N/A) |
54.97 | 99.18 | 80.43% | Details |
| 11/14/2011 | Leerink Swann » Updated 9/14/2012 |
Downgrade | Market Perform (N/A) |
91.00 (N/A) |
57.86 | 99.18 | 71.41% | Details |
| 4/7/2011 | Citadel Securities | New Coverage | Neutral (N/A) |
N/A (N/A) |
54.03 | 99.18 | 83.56% | Details |
| 1/4/2011 | BofA/Merrill Lynch | Upgrade | Neutral (N/A) |
N/A (N/A) |
55.55 | 99.18 | 78.54% | Details |
